Dergham, A.P.; Vaz de Paula, C.B.; Nagashima, S.; Olandoski, M.; de Noronha, L.; Sotomaior, V.S.
Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study. J. Pers. Med. 2023, 13, 1045.
https://doi.org/10.3390/jpm13071045
AMA Style
Dergham AP, Vaz de Paula CB, Nagashima S, Olandoski M, de Noronha L, Sotomaior VS.
Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study. Journal of Personalized Medicine. 2023; 13(7):1045.
https://doi.org/10.3390/jpm13071045
Chicago/Turabian Style
Dergham, Ana Paula, Caroline Busatta Vaz de Paula, Seigo Nagashima, Márcia Olandoski, Lucia de Noronha, and Vanessa Santos Sotomaior.
2023. "Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study" Journal of Personalized Medicine 13, no. 7: 1045.
https://doi.org/10.3390/jpm13071045
APA Style
Dergham, A. P., Vaz de Paula, C. B., Nagashima, S., Olandoski, M., de Noronha, L., & Sotomaior, V. S.
(2023). Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study. Journal of Personalized Medicine, 13(7), 1045.
https://doi.org/10.3390/jpm13071045
